Cargando…

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria

Detalles Bibliográficos
Autores principales:	Watson, James A., White, Nicholas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614973/ https://www.ncbi.nlm.nih.gov/pubmed/35857669 http://dx.doi.org/10.1056/NEJMc2205922

Ejemplares similares

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012)

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2019)

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
por: Bright, A. Taylor, et al.
Publicado: (2013)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Management of relapsing Plasmodium vivax malaria
por: Chu, Cindy S, et al.
Publicado: (2016)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Determinants of relapse periodicity in Plasmodium vivax malaria
por: White, Nicholas J
Publicado: (2011)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study
por: Pareek, Anil, et al.
Publicado: (2015)

A Comparison of Two Short-Course Primaquine Regimens for the Treatment and Radical Cure of Plasmodium vivax Malaria in Thailand
por: Pukrittayakamee, Sasithon, et al.
Publicado: (2010)

The prevention and treatment of Plasmodium vivax malaria
por: Chu, Cindy S., et al.
Publicado: (2021)

The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment
por: Sortica, Vinicius A, et al.
Publicado: (2016)

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022)

Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
por: Rajgor, D. D., et al.
Publicado: (2014)

Mass primaquine treatment to eliminate vivax malaria: lessons from the past
por: Kondrashin, Anatoly, et al.
Publicado: (2014)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
por: Chamnanphon, Monpat, et al.
Publicado: (2020)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
por: de Pina-Costa, Anielle, et al.
Publicado: (2021)

Evaluation of pharmacokinetics of single-dose primaquine in undernourished versus normally nourished children diagnosed with Plasmodium vivax malaria in Mumbai
por: Gogtay, NJ, et al.
Publicado: (2021)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis
por: Zuluaga-Idarraga, Lina Marcela, et al.
Publicado: (2015)

Primaquine in vivax malaria: an update and review on management issues
por: Fernando, Deepika, et al.
Publicado: (2011)

Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria
por: White, Michael T., et al.
Publicado: (2016)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

The anaemia of Plasmodium vivax malaria
por: Douglas, Nicholas M, et al.
Publicado: (2012)

Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity
por: Ashley, Elizabeth A, et al.
Publicado: (2019)

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
por: Kheng, Sim, et al.
Publicado: (2015)

A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan
por: Leslie, Toby, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_mtcv9o75n4fg6snu1uradc9kqe